Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
3.020
-0.190 (-5.92%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Aquestive Therapeutics Employees
Aquestive Therapeutics had 142 employees as of December 31, 2024. The number of employees increased by 7 or 5.19% compared to the previous year.
Employees
142
Change (1Y)
7
Growth (1Y)
5.19%
Revenue / Employee
$405,359
Profits / Employee
-$310,824
Market Cap
298.59M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AQST News
- 3 days ago - Aquestive Therapeutics: Oral Anaphylaxis NDA Opportunity Spells Buy - Seeking Alpha
- 22 days ago - Aquestive Therapeutics, Inc. (AQST) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Aquestive Therapeutics to Present New Findings on Anaphylm™ (Epinephrine Sublingual Film) at the 2025 AAAAI Annual Meeting - GlobeNewsWire
- 2 months ago - Aquestive Therapeutics: Five Foci For 2025 - Seeking Alpha
- 4 months ago - Undercovered Dozen: Asbury Automotive, Globalstar, Northland Power, Aquestive Therapeutics + - Seeking Alpha
- 5 months ago - Aquestive Therapeutics, Inc. (AQST) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Aquestive: Rare Opportunity With Dual Platform Strategy - Seeking Alpha